Request a Quote
Part detail

RFQ For 13405 NSN part by Lyphomed Inc with NSN 6505011699573

13405NSN6505-01-169-9573CAGE60567

Dopamine Hydrochloride Injection

Detailed description

13405 procurement notes

Thank you for having an interest in part number 13405, an item from Lyphomed Inc (CAGE Code 10001) that is listed with the description - Support. Be sure to review the details provided on this page, and should you wish to move forward with procurement, fill out and submit the Request for Quote (RFQ) form provided below at your earliest convenience.

If you also require other items from FSC or wish to speak with staff directly, do not hesitate to give us a call or email at any time. We are ready to support you with competitive options for part number 13405and other items of interest, so be sure to get in touch today!

Specifications

Reference data

Manufacturer
Lyphomed Inc
Part number
13405
NSN
6505-01-169-9573
NIIN
01-169-9573
FSC
6505 Drugs and Biologicals
CAGE code
60567
INC code
41749
Country
USA
Part type
Dopamine Hydrochloride Injection
Sub part type
—
Specification
—
Multi-line procurement

Sourcing more than one part?

Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.

Compliance
  • AS9120:2025· Aerospace QMS
  • ISO 9001:2015· Quality Management
  • FAA AC 00-56B· Voluntary Industry Distributor Accreditation
  • U.S. ONLY· Fulfillment

NSN Information for Part Number 13405 with NSN 6505-01-169-9573, 6505011699573

NSNFSCNIINCLSHazmatDEMILCancelled NSN
6505011699573

Item Description:

Dopamine Hydrochloride Injection

6505011699573MP
CIICHCCESDPMICCriticalityENAC
U U
Part NumberISCRNVCRNCCHCCMSDSSADC
13405515

Characteristics Data of NSN 6505-01-169-9573, 6505011699573

MRCCriteriaCharacteristic
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH80.000 MILLIGRAMS DOPAMINE PER MILLILITER
CBBLFEATURES PROVIDEDSTERILE
CQCTPRIMARY CONTAINER TYPEVIAL
CRLKPRIMARY CONTAINER CONTENT QUANTITY5.000 MILLILITERS
CSCWTOTAL PRIMARY CONTAINER QUANTITY25
FEATSPECIAL FEATURESNONPYROGENIC; TO BE DILUTED FOR INTRAVENOUS USE
MDESMEDICAL DESIGNATIONUNITED STATES PHARMACOPEIA